SPC512
Belzútifan eða lyfjafræðilega viðunandi salt þar af, sérstakleg belzútifan / Belzutifan, or a pharmaceutically acceptable salt thereof, particularly belzutifan
Status:
UmsóknApplication date:
6.5.2025Application published:
1.6.2025
Medicine name:
WeliregMedicine for children:
No
Timeline
Today
6.5.2025Application
1.6.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1893Date:
12.2.2025
Owner
Name:
Peloton Therapeutics, Inc.Address:
2330 Inwood Road Suite 226, Dallas, TX 75235-7323 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3417851